Atlas Trials

A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test

Clinical trial NCT02738684 · UNKNOWN

Trial details

NCT number
NCT02738684
Sponsor
Southwest Hospital, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Adenocarcinoma
Start date
2016-04-01
Primary completion
2018-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.